117 related articles for article (PubMed ID: 17220342)
21. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Riedijk SR; van Dooren S; Tibben A
Psychooncology; 2007 Apr; 16(4):320-8. PubMed ID: 16909428
[TBL] [Abstract][Full Text] [Related]
22. Psychological and genetic counseling implications for adolescent daughters of mothers with breast cancer.
Cappelli M; Verma S; Korneluk Y; Hunter A; Tomiak E; Allanson J; DeGrasse C; Corsini L; Humphreys L
Clin Genet; 2005 Jun; 67(6):481-91. PubMed ID: 15857415
[TBL] [Abstract][Full Text] [Related]
23. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.
O'Neill SC; DeMarco T; Peshkin BN; Rogers S; Rispoli J; Brown K; Valdimarsdottir H; Schwartz MD
Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):251-9. PubMed ID: 17024668
[TBL] [Abstract][Full Text] [Related]
24. Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.
Cypowyj C; Eisinger F; Huiart L; Sobol H; Morin M; Julian-Reynier C
Psychooncology; 2009 Feb; 18(2):209-15. PubMed ID: 19061202
[TBL] [Abstract][Full Text] [Related]
25. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.
Maheu C; Thorne S
Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940
[TBL] [Abstract][Full Text] [Related]
26. Risk perception among women receiving genetic counseling: a population-based follow-up study.
Mikkelsen EM; Sunde L; Johansen C; Johnsen SP
Cancer Detect Prev; 2007; 31(6):457-64. PubMed ID: 18061369
[TBL] [Abstract][Full Text] [Related]
27. Uptake of testing for BRCA1/2 mutations in South East Scotland.
Holloway SM; Bernhard B; Campbell H; Lam WW
Eur J Hum Genet; 2008 Aug; 16(8):906-12. PubMed ID: 18285832
[TBL] [Abstract][Full Text] [Related]
28. Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.
Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Scarpi E; Falcini F; Strada M; Morini N; Naldoni C; Amadori D; Calistri D
Breast Cancer Res Treat; 2008 Nov; 112(2):343-9. PubMed ID: 18092194
[TBL] [Abstract][Full Text] [Related]
29. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
Anagnostopoulos T; Pertesi M; Konstantopoulou I; Armaou S; Kamakari S; Nasioulas G; Athanasiou A; Dobrovic A; Young MA; Goldgar D; Fountzilas G; Yannoukakos D
Breast Cancer Res Treat; 2008 Jul; 110(2):377-85. PubMed ID: 17902052
[TBL] [Abstract][Full Text] [Related]
30. The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations.
Geirdal AØ; Dahl AA
Psychooncology; 2008 Jan; 17(1):49-57. PubMed ID: 17385192
[TBL] [Abstract][Full Text] [Related]
31. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
[TBL] [Abstract][Full Text] [Related]
32. Implications of living with a strong family history of breast cancer.
Maheu C
Can J Nurs Res; 2009 Jun; 41(2):100-12. PubMed ID: 19650516
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
34. Hereditary melanoma and predictive genetic testing: why not?
Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
[TBL] [Abstract][Full Text] [Related]
35. [Psychosocial factors associated with genetic testing for certain hereditary types of neoplasms].
Franková V; Zidovská J; Krutílková V; Havlovicová M; Goetz P
Cas Lek Cesk; 2003; 142(10):599-602. PubMed ID: 14635423
[TBL] [Abstract][Full Text] [Related]
36. The phases of disclosing BRCA1/2 genetic information to offspring.
Clarke S; Butler K; Esplen MJ
Psychooncology; 2008 Aug; 17(8):797-803. PubMed ID: 18646247
[TBL] [Abstract][Full Text] [Related]
37. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
[TBL] [Abstract][Full Text] [Related]
38. Benefit finding in response to BRCA1/2 testing.
Low CA; Bower JE; Kwan L; Seldon J
Ann Behav Med; 2008 Feb; 35(1):61-9. PubMed ID: 18347905
[TBL] [Abstract][Full Text] [Related]
39. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
Metcalfe KA; Poll A; O'Connor A; Gershman S; Armel S; Finch A; Demsky R; Rosen B; Narod SA
Clin Genet; 2007 Sep; 72(3):208-17. PubMed ID: 17718858
[TBL] [Abstract][Full Text] [Related]
40. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
